Immuno-Biological Laboratories (4570) · InitiativeRestated
Development and launch of an incretin and insulin high-sensitivity assay kit
First written in FY2017. 1 of 2 entries say "Restated". Latest entry: FY2020.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
Development and launch of an incretin and insulin high-sensitivity assay kitA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2020RestatedAnnual report
「We developed and launched a high-sensitivity measurement system for insulin, which controls blood glucose levels.」
The company is rechecking its track record in developing and launching the high-sensitivity insulin measurement system. - FY2017First statedAnnual report
「As a result, sales of the GIP and GLP-1 High sensitivity kits began between May and July 2016. In addition, we developed a high-sensitivity insulin measurement system that can be used in animal experiments involving mice and rats, and launched it in September of the same year.」
Developed and launched high-sensitivity GIP and GLP-1 kits and a high-sensitivity insulin measurement system for animal experiments.